
British Patient Capital Invests £10 Million in Maxion Therapeutics, Part of Series A Financing Round
British Patient Capital, a commercial subsidiary of the British Business Bank, announced a £10 million (US$13 million) investment in Maxion Therapeutics (Maxion), a UK-based biotechnology company developing antibody-based therapeutics based on its …